The GIST of targeted therapy for malignant melanoma. [electronic resource]
Producer: 20150212Description: 2059-67 p. digitalISSN:- 1534-4681
- Antineoplastic Agents -- therapeutic use
- Benzamides -- adverse effects
- Drug Resistance, Neoplasm
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate
- Indoles -- adverse effects
- Melanoma -- drug therapy
- Molecular Targeted Therapy
- Mutation
- Piperazines -- adverse effects
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins c-kit -- genetics
- Pyrimidines -- adverse effects
- Sulfonamides -- adverse effects
- Vemurafenib
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.